Allomalformin

International Journal of Peptide and Protein Research
|July 1, 1982
PubMed

Insights

Researchers synthesized allomalformin to explain erroneous malformin sequencing. Allomalformin and malformin share biological activity but differ in chromatography, with allomalformin absent in natural samples. This study clarifies malformin

Area of Science:

  • Biochemistry
  • Natural Product Chemistry
  • Peptide Synthesis

Background:

  • Malformin is a microbial peptide with a complex structure.
  • Previous sequence assignments for malformin were found to be erroneous.
  • A potential sequence isomer, allomalformin, was proposed as a source of error.

Purpose of the Study:

  • To synthesize and characterize 3-isoleucine-5-valine malformin (allomalformin).
  • To compare allomalformin with natural and synthetic malformin to identify sources of sequencing errors.
  • To elucidate the correct partial sequence of malformin.

Main Methods:

  • Chemical synthesis of allomalformin.
  • Comparative analysis using biological activity assays, Circular Dichroism (CD), Optical Rotatory Dispersion (ORD), High-Pressure Liquid Chromatography (HPLC), and Thin-Layer Chromatography (TLC).
  • Partial acid hydrolysis of malformin and its analogs.

Main Results:

  • Allomalformin is biologically active and conformationally similar to malformin, but chromatographically distinct.
  • Allomalformin was not detected in natural malformin samples by TLC or HPLC.
  • A lower homolog, 5-valine malformin, was detected in natural samples and identified as the source of misleading hydrolysis fragments (Val-Cys and Val-Ala).

Conclusions:

  • The erroneous Cys-Val-Cys sequence assignment for malformin likely resulted from the presence of a lower homolog (5-valine malformin).
  • Partial acid hydrolysis of the lower homolog, not malformin itself, generated fragments that led to the incorrect sequence.
  • This study clarifies the structural basis for previous malformin sequencing errors.

Related Concept Videos

Mutations01:39

Mutations

Overview
Nondisjunction01:29

Nondisjunction

During meiosis, chromosomes occasionally separate improperly. This occurs due to failure of homologous chromosome separation during meiosis I or failed sister chromatid separation during meiosis II. In some species, notably plants, nondisjunction can result in an organism with an entire additional set of chromosomes, which is called polyploidy. In humans, nondisjunction can occur during male or female gametogenesis and the resulting gametes possess one too many or one too few chromosomes.
Nondisjunction01:29

Nondisjunction

During meiosis, chromosomes occasionally separate improperly. This occurs due to failure of homologous chromosome separation during meiosis I or failed sister chromatid separation during meiosis II. In some species, notably plants, nondisjunction can result in an organism with an entire additional set of chromosomes, which is called polyploidy. In humans, nondisjunction can occur during male or female gametogenesis and the resulting gametes possess one too many or one too few chromosomes.
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Nondisjunction01:21

Nondisjunction

Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers.  Nondisjunction is common during anaphase I or anaphase II of meiosis.  Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold sister...
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism01:21

Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism

Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...